1,2,4-Triazol-3-yl-thiopropyl-tetrahydrobenzazepines: A Series of Potent and Selective Dopamine D3 Receptor Antagonists
摘要:
The discovery of new highly potent and selective dopamine D-3 receptor antagonists has recently permitted characterization of the role of the dopamine D-3 receptor in a wide range, of preclinical animal models. A novel series of 1,2,4-triazol-3-yl-thiopropyl-tetrahydrobenzazepines demonstrating a high level of D3 affinity and selectivity with an excellent pharmacokinetic profile is reported here. In particular, the pyrazolyl derivative 35 showed good oral bioavailability and brain penetration associated with high potency and selectivity in vitro. In vivo characterization of 35 confirmed that this compound blocks the expression of nicotine- and cocaine-conditioned place preference in the rat, prevents nicotine-triggered reinstatement of nicotine- seeking behavior in the rat, reduces oral operant alcohol self- administration in the mouse, increases extracellular levels of acetylcholine in the rat medial prefrontal cortex, and potentiates the amplitude of the relative cerebral blood volume response to d-amphetamine in a regionally specific manner in the rat brain.
[EN] TETRAHYDROBENZAZEPINE DERIVATIVES AS MODULATORS OF DOPAMINE D3 RECEPTORS (ANTIPSYCHOTIC AGENTS) [FR] DERIVES DE TETRAHYDROBENZAZEPINE COMME MODULATEURS DE RECEPTEURS D3 DE LA DOPAMINE (AGENTS ANTIPSYCHOTIQUES)
COMPOUNDS HAVING AFFINITY FOR DOPAMINE D3 RECEPTOR AND USES THEREOF"
申请人:Bonanomi Giorgio
公开号:US20100016287A1
公开(公告)日:2010-01-21
Compounds of formula (I)
wherein A is a 5 or 6 membered heteroaromatic ring or a 5 or 6 membered heterocyclic ring, and which are useful for treating mental disorders such as schizophrenia are set out herein.
Tetrahydrobenzazepine Derivatives as Modulators of Dopamine D3 Receptors (Antipsychotic Agents)
申请人:Arista Luca
公开号:US20080139532A1
公开(公告)日:2008-06-12
The present invention relates to novel compounds of formula (I) or a pharmaceutically acceptable salt thereof, processes for their preparation, intermediates used in these processes, pharmaceutical compositions containing them and their use in therapy, as modulators of dopamine D
3
receptors, e.g. as agents to treat various aspects drug dependency or as antipsychotic agents.
Compounds having affinity for dopamine D3 receptor and uses thereof
申请人:Glaxo Group Limited
公开号:US07989444B2
公开(公告)日:2011-08-02
Compounds of formula (I)
wherein A is a 5 or 6 membered heteroaromatic ring or a 5 or 6 membered heterocyclic ring, and which are useful for treating mental disorders such as schizophrenia are set out herein.
[EN] COMPOUNDS HAVING AFFINITY FOR DOPAMINE D3 RECEPTOR AND USES THEREOF<br/>[FR] COMPOSES PRESENTANT UNE AFFINITE POUR LE RECEPTEUR DE LA DOPAMINE D3 ET LEURS UTILISATIONS
申请人:GLAXO GROUP LTD
公开号:WO2005118549A3
公开(公告)日:2006-04-13
TETRAHYDROBENZAZEPINE DERIVATIVES AS MODULATORS OF DOPAMINE D3 RECEPTORS (ANTIPSYCHOTIC AGENTS)